NovoCure Ltd. (NVCR)
NASDAQ · Healthcare
NovoCure Ltd. Shareholder Equity 2013–2025
NovoCure Ltd. annual shareholder equity history from 2014 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- NovoCure Ltd. shareholder equity as of December 31, 2025: 340.5M, a 5.47% decrease year-over-year.
- NovoCure Ltd. shareholder equity for 2025 were 340.5M, a 5.47% decrease from 2024.
- NovoCure Ltd. shareholder equity for 2024 were 360.2M, a 0.64% decrease from 2023.
- NovoCure Ltd. shareholder equity for 2023 were 362.5M, a 17.83% decrease from 2022.
- NovoCure Ltd. shareholder equity for 2022 were 441.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| NovoCure Ltd. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $340 |
| 2024 | $360 |
| 2023 | $362 |
| 2022 | $441 |
| 2021 | $410 |
| 2020 | $477 |
| 2019 | $218 |
| 2018 | $112 |
| 2017 | $114 |
| 2016 | $142 |
| 2015 | $251 |
| 2014 | $98 |
NovoCure Ltd. Shareholder Equity — FAQ
NovoCure Ltd. (NVCR) shareholder equity over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVCR's shareholder equity history?
The chart and table above show NovoCure Ltd.'s shareholder equity by year and by quarter, including the growth rate.